Section 251.300 Infection Control
a) The
hospital shall designate a person or persons as Infection Prevention and
Control Professionals to develop and implement policies governing control of
infections and communicable diseases. The Infection Prevention and Control
Professionals shall be qualified through education, training, experience,
and/or certification, and the qualifications shall be documented.
b) A
multidisciplinary Infection Control Committee, composed at least of members of
the medical staff and nursing staff, the Infection Prevention and Control
Professionals, and the supervisor of Central Sterile Supply and the hospital administration,
shall be responsible for investigations and recommendations for the prevention
and control of infections within the hospital. This Committee shall perform
an annual facility-wide infection control risk assessment. (Section 7 of
the Act)
c) Policies
and procedures for reporting cases of communicable diseases and for the care of
patients with communicable diseases shall be in accordance with the Control of
Communicable Diseases Code, the Control of Sexually Transmissible Diseases Code
and the Control of Tuberculosis Code.
d) When
patients having a communicable disease, or presenting signs and symptoms
suggestive of such diagnosis, are admitted, proper precautionary measures shall
be taken to avoid cross-infection to hospital personnel, other patients, or the
public.
e) The
hospital shall provide facilities and equipment for the isolation of known or suspected
cases of infectious disease.
f) Policies
and procedures for handling infectious cases shall include orders for nursing
and non-professional staffs providing for proper isolation technique.
g) All
persons who care for patients with or suspected of having a communicable
disease, or whose work brings them in contact with materials that are potential
conveyors of communicable disease, shall take appropriate safeguards to avoid
transmission of the disease agent.
h) The
hospital shall develop and implement comprehensive interventions to prevent and
control multidrug-resistant organisms (MDROs), including methicillin-resistant
Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and
certain gram-negative bacilli (GNB), that take into consideration guidelines of
the Centers for Disease Control and Prevention for the management of MDROs in
healthcare settings, including the "2007 Guideline for Isolation
Precautions: Preventing Transmission of Infectious Agents in Healthcare
Settings" and "Guidelines for Hand Hygiene in Health-Care Settings".
(Section 7 of the Act)
i) The
hospital shall comply with the Centers for Disease Control and Prevention
publication "Guidelines for Infection Control in Health Care Personnel".
j) The
multidisciplinary Infection Control Committee shall be responsible for
developing, implementing, monitoring, and enforcing a hand hygiene program in
the hospital. For the purposes of this Part, "hand hygiene" is a
general term that applies to hand washing with plain soap and water; antiseptic
hand wash using soap containing antiseptic agents and water; antiseptic hand
rub using a waterless antiseptic product, most often alcohol based, rubbed on
the surface of the hands; or surgical hand antiseptic.
1) The
Committee shall assess the current practices and compliance, assess hand
hygiene products that are currently being used, solicit input from clinical
staff, and develop a hand hygiene program for all staff.
2) All
staff (including contractual and medical) shall be educated in the hand hygiene
program during initial orientation and at least annually. This education shall
be documented.
3) The
program shall have clear written goals that require quantitative, time-specific
improvement targets.
4) The
Committee shall develop and implement measurement tools to be used to assure
ongoing compliance with the program.
5) The
program shall incorporate the requirements for hand hygiene in educational
materials presented to all staff on an ongoing basis; engage patients and
families in the hand hygiene efforts; monitor compliance of all staff with
recommended measurement tools for hand hygiene, including immediate feedback to
personnel; and track compliance over time.
6) The
results of the monitoring shall be incorporated in the Quality
Assurance/Quality Improvement Program.
k) Contaminated
material shall be handled and disposed of in a manner designed to prevent the
transmission of the infectious agent.
l) Thorough
hand hygiene shall be required after touching any contaminated or infected
material.
m) The
hospital shall establish a systematic plan of checking and recording cases of
infection, known or suspected, that develop in the institution; these cases
shall be reported to the Infection Control Committee and hospital
administration. The Committee shall be empowered and directed to investigate
health care-associated infections to determine the causative organism and its
possible sources. The findings and recommendations of the Infection Control
Committee shall be reported to the medical staff and administration for
corrective action.
n) Policies
and procedures related to this Section and to the following items shall be
developed:
1) The
admission and isolation of patients with specific and/or suspected infectious
diseases and protective isolation of appropriate patients.
2) In-service
education programs on the control of infectious diseases.
3) Policies
and procedures for isolation techniques appropriate to the working diagnosis of
the patient and protective routines for personnel and visitors.
4) The
recording and reporting of all infections of clean surgical cases to the
Infection Control Committee and procedures for the investigation of those
cases.
o) In
order to improve the prevention of hospital-associated bloodstream infections
due to methicillin-resistant Staphylococcus aureaus (MRSA) and pursuant to
Section 2310-312 of the Department of Public Health Powers and Duties Law of
the Civil Administrative Code of Illinois, the hospital shall establish an
MRSA control program that requires:
1) Identification
of all MRSA-colonized patients in all intensive care units, and other at-risk
patients identified by the hospital, through active surveillance testing.
2) Isolation
of identified MRSA-colonized or MRSA-infected patients in an appropriate
manner.
3) Monitoring
and strict enforcement of hand hygiene requirements.
4) Maintenance
of records and reporting of cases under Section 10 of the MRSA
Screening and Reporting Act. (Section 5 of the MRSA Screening and Reporting
Act)